{"id":"W1563283949","doi":"10.1002/cncr.29161","title":"Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":538,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Alexander Family Foundation; McKnight Foundation","keywords":"Medicine; Gemcitabine; Common Terminology Criteria for Adverse Events; Pancreatic cancer; Clinical endpoint; Adverse effect; Radiation therapy; Toxicity; Internal medicine; Quality of life (healthcare); Adenocarcinoma; Radiosurgery; Clinical trial; Cancer; Radiology; Gastroenterology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04441011237090429,"score_gpt":0.4011181487900463,"score_spread":0.3567080364191419,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}